267 related articles for article (PubMed ID: 19354075)
1. Omalizumab in idiopathic anaphylaxis.
Warrier P; Casale TB
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):257-8. PubMed ID: 19354075
[No Abstract] [Full Text] [Related]
2. Effects of omalizumab in patients with food allergy.
Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab as add-on therapy to inhaled steroids for asthma.
Hadj Tahar A
Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
[TBL] [Abstract][Full Text] [Related]
4. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
5. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma.
Limb SL; Starke PR; Lee CE; Chowdhury BA
J Allergy Clin Immunol; 2007 Dec; 120(6):1378-81. PubMed ID: 17936893
[TBL] [Abstract][Full Text] [Related]
6. Anaphylaxis to vapors of roasting chicken controlled by omalizumab.
Barnig C; Hilger C; Muti D; Blaumeiser M; Purohit A; Hentges F; de Blay F
J Investig Allergol Clin Immunol; 2012; 22(6):439-40. PubMed ID: 23101190
[No Abstract] [Full Text] [Related]
7. Anaphylaxis following the first ingestion of lychee fruit: clinical features and immunological cross-reactivity implications.
Garrido S; García BE; Echechipía S; Sanz ML; Ariz S; Tabar AI
Allergy; 2007 Aug; 62(8):962-3. PubMed ID: 17484730
[No Abstract] [Full Text] [Related]
8. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
Holgate S; Bousquet J; Wenzel S; Fox H; Liu J; Castellsague J
Curr Med Res Opin; 2001; 17(4):233-40. PubMed ID: 11922396
[TBL] [Abstract][Full Text] [Related]
9. Food-induced anaphylaxis.
Sampson HA
Novartis Found Symp; 2004; 257():161-71; discussion 171-6, 207-10, 276-85. PubMed ID: 15025397
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab in persistent severe bakers' asthma.
Olivieri M; Biscardo CA; Turri S; Perbellini L
Allergy; 2008 Jun; 63(6):790-1. PubMed ID: 18445199
[No Abstract] [Full Text] [Related]
11. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
Busse W; Corren J; Lanier BQ; McAlary M; Fowler-Taylor A; Cioppa GD; van As A; Gupta N
J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.
Kontou-Fili K; Filis CI; Voulgari C; Panayiotidis PG
Ann Allergy Asthma Immunol; 2010 Jun; 104(6):537-9. PubMed ID: 20568389
[No Abstract] [Full Text] [Related]
14. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
[TBL] [Abstract][Full Text] [Related]
15. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.
Corren J; Shapiro G; Reimann J; Deniz Y; Wong D; Adelman D; Togias A
J Allergy Clin Immunol; 2008 Feb; 121(2):506-11. PubMed ID: 18269927
[TBL] [Abstract][Full Text] [Related]
16. Provocation tests for the diagnosis of food-dependent exercise-induced anaphylaxis.
Asaumi T; Yanagida N; Sato S; Shukuya A; Nishino M; Ebisawa M
Pediatr Allergy Immunol; 2016 Feb; 27(1):44-9. PubMed ID: 26360640
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
[TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab.
Heffler E; Fichera S; Nicolosi G; Crimi N
J Allergy Clin Immunol Pract; 2017; 5(3):852-854. PubMed ID: 28258855
[No Abstract] [Full Text] [Related]
19. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis.
Cox L; Platts-Mills TA; Finegold I; Schwartz LB; Simons FE; Wallace DV; ;
J Allergy Clin Immunol; 2007 Dec; 120(6):1373-7. PubMed ID: 17996286
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
Ayres JG; Higgins B; Chilvers ER; Ayre G; Blogg M; Fox H
Allergy; 2004 Jul; 59(7):701-8. PubMed ID: 15180756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
